Answer
Lutetium (177Lu) vipivotide tetraxetan (Pluvicto) has a geometric mean terminal elimination half-life of 41.6 hours (CV 68.8%), with bi-exponential elimination.
Sources for this answer
- Pluvicto 1,000 MBq/mL solution for injection/infusionNovartis Pharmaceuticals UK Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 7Document updated
Sources checked